Roche Holding AG (RHHBY)
Company Info
Highlights
$249.30B
$1.53
25.51
0.74
$30.19 - $42.88
$46.42
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
Roche Holding AG (RHHBY) returned 15.62% year-to-date (YTD) and 22.91% over the past 12 months. Over the past 10 years, RHHBY returned 3.92% annually, underperforming the S&P 500 benchmark at 10.89%.
RHHBY
15.62%
0.33%
12.52%
22.91%
0.46%
3.92%
^GSPC (Benchmark)
1.30%
12.79%
1.49%
12.35%
15.12%
10.89%
Monthly Returns
The table below presents the monthly returns of RHHBY, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 12.53% | 6.34% | 1.87% | -0.92% | -4.27% | 15.62% | |||||||
| 2024 | -3.01% | -6.86% | 1.66% | -6.58% | 7.34% | 8.31% | 16.84% | 4.49% | -5.62% | -2.85% | -6.62% | -3.75% | 0.36% |
| 2023 | -0.00% | -7.92% | 3.17% | 9.37% | 0.94% | -3.51% | 1.31% | -5.35% | -7.37% | -4.72% | 4.21% | 7.54% | -4.02% |
| 2022 | -6.00% | -2.80% | 7.44% | -6.54% | -7.88% | -1.95% | -0.58% | -2.48% | 0.45% | 1.77% | -1.02% | -4.33% | -22.21% |
| 2021 | -0.98% | -5.32% | 1.75% | 0.37% | 7.49% | 7.38% | 2.70% | 4.06% | -9.46% | 6.29% | 0.93% | 5.97% | 21.57% |
| 2020 | 2.80% | -4.57% | 4.91% | 7.15% | -0.28% | 0.07% | -0.65% | 1.39% | -2.04% | -6.59% | 2.08% | 7.40% | 11.22% |
| 2019 | 7.14% | 4.05% | 2.47% | -3.87% | -0.54% | 6.75% | -4.42% | 1.88% | 6.64% | 3.21% | 2.53% | 5.42% | 35.07% |
| 2018 | -1.84% | -6.74% | 2.78% | -2.88% | -3.56% | 3.06% | 11.00% | 0.95% | -2.58% | 0.66% | 6.82% | -4.16% | 2.16% |
| 2017 | 5.01% | 1.54% | 8.71% | 2.09% | 5.14% | -7.50% | -0.31% | 0.15% | 0.79% | -9.64% | 9.22% | -0.00% | 14.28% |
| 2016 | -5.95% | -1.14% | -1.32% | 3.09% | 4.15% | 0.21% | -2.61% | -4.80% | 1.37% | -7.41% | -3.19% | 2.77% | -14.53% |
| 2015 | -0.68% | 1.10% | 4.01% | 4.36% | 7.19% | -8.81% | 2.97% | -5.41% | -3.53% | 2.91% | -1.24% | 2.93% | 4.72% |
| 2014 | -2.28% | 11.90% | 1.27% | -2.84% | 0.65% | 1.11% | -2.61% | 0.51% | 1.31% | -0.49% | 1.77% | -9.26% | -0.22% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
With an overall rank of 81, RHHBY is among the top 19% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Roche Holding AG (RHHBY) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
Roche Holding AG provided a 3.49% dividend yield over the last twelve months, with an annual payout of $1.36 per share. The company has been increasing its dividends for 2 consecutive years.
| Period | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $1.36 | $1.39 | $1.29 | $1.27 | $1.28 | $1.15 | $1.09 | $1.11 | $1.02 | $1.03 | $1.08 | $1.10 |
Dividend yield | 3.49% | 3.99% | 3.55% | 3.23% | 2.47% | 2.63% | 2.69% | 3.58% | 3.22% | 3.62% | 3.14% | 3.23% |
Monthly Dividends
The table displays the monthly dividend distributions for Roche Holding AG. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | $0.00 | $0.00 | $1.36 | $0.00 | $0.00 | $1.36 | |||||||
| 2024 | $0.00 | $0.00 | $1.39 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.39 |
| 2023 | $0.00 | $0.00 | $1.29 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.29 |
| 2022 | $0.00 | $0.00 | $1.27 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.27 |
| 2021 | $0.00 | $0.00 | $1.28 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.28 |
| 2020 | $0.00 | $0.00 | $1.15 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.15 |
| 2019 | $0.00 | $0.00 | $1.09 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.09 |
| 2018 | $0.00 | $0.00 | $1.11 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.11 |
| 2017 | $0.00 | $0.00 | $1.02 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.02 |
| 2016 | $0.00 | $0.00 | $1.03 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.03 |
| 2015 | $0.00 | $0.00 | $1.08 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.08 |
| 2014 | $1.10 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.10 |
Dividend Yield & Payout
Dividend Yield
Roche Holding AG has a dividend yield of 3.49%, which is quite average when compared to the overall market.
Payout Ratio
Roche Holding AG has a payout ratio of 94.47%, which is above the market average. This might signify the company's strong earnings or financial health. However, it could also hint at a more mature business phase with potentially slower growth.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the Roche Holding AG. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Roche Holding AG was 50.12%, occurring on Feb 26, 2014. Recovery took 1 trading session.
The current Roche Holding AG drawdown is 18.41%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -50.12% | Feb 26, 2014 | 1 | Feb 26, 2014 | 1 | Feb 27, 2014 | 2 |
| -45.82% | Feb 29, 2008 | 253 | Mar 2, 2009 | 566 | May 27, 2011 | 819 |
| -40.8% | Apr 11, 2022 | 517 | May 2, 2024 | — | — | — |
| -30.64% | Jun 4, 2002 | 196 | Mar 13, 2003 | 65 | Jun 16, 2003 | 261 |
| -27.29% | Jun 1, 2015 | 387 | Dec 8, 2016 | 555 | Feb 26, 2019 | 942 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Roche Holding AG over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of Roche Holding AG, comparing actual results with analytics estimates. In the past quarter, the company did not meet analyst expectations for EPS, resulting in a surprise of -2.5%.
Valuation
The Valuation section provides an overview of how Roche Holding AG is priced in the market compared to other companies in the Drug Manufacturers - General industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for RHHBY, comparing it with other companies in the Drug Manufacturers - General industry. Currently, RHHBY has a P/E ratio of 25.5. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for RHHBY compared to other companies in the Drug Manufacturers - General industry. RHHBY currently has a PEG ratio of 0.7. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for RHHBY relative to other companies in the Drug Manufacturers - General industry. Currently, RHHBY has a P/S ratio of 4.0. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for RHHBY in comparison with other companies in the Drug Manufacturers - General industry. Currently, RHHBY has a P/B value of 6.6. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |